
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Gains Momentum with Next-Gen Therapies | CI Insights
CIDP treatment evolves with novel approvals like Vyvgart Hytrulo and HYQVIA, offering patients new, less invasive and more convenient therapy options. AUSTIN, TX, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- Chronic Inflammatory …